GM said that LMR battery cells use a higher proportion of the more affordable manganese and less of the more expensive nickel while delivering greater capacity and energy density.
A Microsoft spokesperson told CNBC that the software giant continues to implement “organizational changes necessary to best position the company for success in a dynamic marketplace.”
In the second quarter, the firm expects to announce data from a phase 2 trial of its investigational therapy, Pemvidutide, in treating metabolic dysfunction-associated steatohepatitis (MASH).
CEO Larry Coben said the transaction is financially compelling as it strengthens the company’s credit profile, boosts its growth rate, and supports continued robust capital returns.
The firm's report echoes the sentiment across the travel and hospitality sector, where demand is strained due to macroeconomic uncertainties and geopolitical unrest.
CEO Shankar Musunuri said that the company is “on track” to meet its goal of submitting applications to the FDA requesting approval for the distribution of three of its products in the next three years.
